[Undesired drug side effects and drug-induced damage. II. Centrally acting drugs].
It is reported on the most important disease as a sequel of the intake of central-effective pharmaca (sedatives, hypnotics antiepileptics, analgesics and psychopharmaca). Psychopathological and neurological syndromes are described in detail.
D000328:Adult; D000639:Amitriptyline / Q000009:adverse effects; D001342:Autonomic Nervous System Diseases / Q000139:chemically induced; D001480:Basal Ganglia Diseases / Q000139:chemically induced; D002491:Central Nervous System Agents / Q000009:adverse effects*; D002526:Cerebellar Diseases / Q000139:chemically induced; D002561:Cerebrovascular Disorders / Q000139:chemically induced; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D007415:Intestinal Obstruction / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D001523:Mental Disorders / Q000139:chemically induced; D011605:Psychoses, Substance-Induced / Q000209:etiology; D019966:Substance-Related Disorders / Q000209:etiology; D013405:Suicide; D013406:Suicide, Attempted; D014555:Urination Disorders / Q000139:chemically induced
D002491:Central Nervous System Agents; D000639:Amitriptyline
Unerwünschte Arzneimittelnebenwirkungen und Arzneimittelschäden. II. Zentralwirksame Pharmaka.